Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/1998
08/20/1998WO1998035567A1 Gelling agents and gels containing them
08/20/1998WO1998035562A1 Polynucleotide vaccine formulations
08/20/1998WO1998022136A3 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
08/20/1998WO1998019783A3 Twin surfactants
08/20/1998WO1998019708A3 Method for enhancing the solubility of substantially water-insoluble compounds
08/20/1998WO1998017689A3 Il-12 gene expression and delivery systems and uses
08/20/1998WO1998014215A3 Glycoconjugates as virus cell adhesion inhibitors
08/20/1998EP0880352A3 Stabilization of naloxonhydrochlorid
08/20/1998DE19705963A1 Vernetzte Vinylpolymere mit Gallensäure-Adsorberwirkung Networked vinyl polymers with bile acid Adsorberwirkung
08/20/1998CA2282426A1 Use of heat shock proteins to deliver moieties into cells
08/20/1998CA2281690A1 Method for destroying retinal pigment epithelial cells
08/20/1998CA2281607A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
08/20/1998CA2281602A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998CA2281560A1 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium
08/20/1998CA2280998A1 A pharmaceutical composition for treating hepatitis b virus (hbv) infection
08/20/1998CA2280957A1 Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
08/20/1998CA2280874A1 Bioreductive conjugate for targeting a therapeutic agent
08/20/1998CA2280839A1 Polynucleotide vaccine formulations
08/20/1998CA2280806A1 Inhibition of gene transcription by polyamide dna-binding ligands
08/20/1998CA2279590A1 Targeted therapeutic delivery of vitamin d compounds
08/19/1998EP0858809A1 Method of preventing tpo adsorption and stable tpo-containing composition
08/19/1998EP0858805A2 Transdermal preparations of oxicams
08/19/1998EP0858803A1 Composition for local anesthesia
08/19/1998EP0858344A2 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
08/19/1998EP0858343A1 Continuous low-dose cytokine infusion therapy
08/19/1998EP0858329A1 Novel stable liquid paracetamol compositions, and method for preparing same
08/19/1998EP0858325A1 Stable freeze-dried pharmaceutical formulation
08/19/1998EP0858324A1 Process for aqueous granulation of clarithromycin
08/19/1998EP0858323A1 Process to manufacture implants containing bioactive peptides
08/19/1998EP0768882B1 Carbamazepine medicament with retarded active substance release
08/19/1998EP0758896B1 Topical preparation containing aciclovir
08/19/1998EP0703926B1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
08/19/1998EP0695170A4 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
08/19/1998EP0684997B1 Anthrax toxin fusion proteins and uses thereof
08/19/1998EP0660668B1 Iodine/resin disinfectant and a procedure for the preparation thereof
08/19/1998EP0549592B1 Stabilized retinoid-containing skin care compositions
08/19/1998CN1190897A Stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calctum ions
08/19/1998CN1190896A Stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue
08/19/1998CN1190893A Compound and compositions for delivering active agents
08/19/1998CN1190660A 聚酯 Polyester
08/19/1998CN1190597A Skin-permeated absorption-promoting agent and cosmetics thereof
08/19/1998CA2229966A1 Tasteless forms of basic drugs prepared by adsorption in situ
08/18/1998US5795978 Containing alkyl or alkenl oligoglycoside and fatty alcohol;cosmetics, drugs
08/18/1998US5795966 Antagonists of interleukin-15
08/18/1998US5795916 Diclofenac sodium salt with water and fatty acid dialkylolamide and/or adduct with polyoxyethylene glycol
08/18/1998US5795913 Ophthalmic composition
08/18/1998US5795909 DHA-pharmaceutical agent conjugates of taxanes
08/18/1998US5795896 Consisting of thrombin inhibitor and absorption inhibiting agent
08/18/1998US5795870 Steroid ring with amine group side chains
08/18/1998US5795860 Analogs for specific oligosaccharide-protein interactions and uses therefor
08/18/1998US5795592 Calcium channel blocker
08/18/1998US5795580 Group B streptococcus type V polysaccharide-protein conjugate vaccines
08/18/1998US5795572 Monoclonal antibodies and FV specific for CD2 antigen
08/18/1998US5795567 Polyamines and method for preparation thereof
08/18/1998US5795562 Biodegradable polymer as contrast agents for diagnostic imaging
08/13/1998WO1998035026A1 Polypeptide-polymer conjugates having added and/or removed attachment groups
08/13/1998WO1998034968A1 Polymers incorporating peptides
08/13/1998WO1998034957A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE α-GALACTOSYL EPITOPE
08/13/1998WO1998034956A1 Non-covalent complex comprising at least an antibody and element binding with immunoglobulins associated with an active substance, method of preparing and applications
08/13/1998WO1998034955A1 No-modified hemoglobins and uses therefor
08/13/1998WO1998034910A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/13/1998WO1998034667A1 Gene therapeutic treatment of blood vessel associated disorders
08/13/1998WO1998034655A1 Matrix-free osteogenic devices, implants and methods of use thereof
08/13/1998WO1998034648A1 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
08/13/1998WO1998034647A1 Arginine silicate inositol complex and use thereof
08/13/1998WO1998034646A2 Targeted antioxidants
08/13/1998WO1998034645A1 A composition for administration by the intranasal, sublingual or vaginal route
08/13/1998WO1998034632A1 Compounds and compositions for delivering active agents
08/13/1998WO1998034623A1 Freeze-dried composition containing glycosphingolipid and process for producing the same
08/13/1998WO1998034607A1 Tetrahydrolipstatin containing compositions
08/13/1998WO1998034599A1 Microgranules containing cisplatin
08/13/1998WO1998034596A2 Biocompatible compounds for pharmaceutical drug delivery systems
08/13/1998WO1998034595A1 Medical aerosol formulations
08/13/1998WO1998034594A1 Thimerosal-free preservatives for vaccines
08/13/1998WO1998034593A1 Method of treating dry eye disease with purinergic receptor agonists
08/13/1998WO1998034592A1 Topical drug preparations
08/13/1998WO1998027959A3 New aqueous medicament preparations for the production of propellent gas-free aerosols
08/13/1998WO1998011206A3 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
08/13/1998DE19705233A1 Preparation of stable, orally administered arginine solutions
08/13/1998CA2279986A1 Polypeptide-polymer conjugates having added and/or removed attachment groups
08/13/1998CA2279982A1 Topical drug preparations
08/13/1998CA2279233A1 Arginine silicate complex and use thereof
08/13/1998CA2278784A1 No-modified hemoglobins and uses therefor
08/13/1998CA2278665A1 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
08/13/1998CA2251999A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/12/1998EP0857489A2 Production and use of multimeric hemoglobins
08/12/1998EP0857212A2 Methods and compositions comprising glut-2 and glut-2 chimeras
08/12/1998EP0857207A1 Microporous pathogen-killing composition
08/12/1998EP0857203A2 Methods and compositions to improve germ cell and embryo survival and function
08/12/1998EP0857081A1 Preparation of peptide containing biodegradable microspheres by melt process
08/12/1998EP0857069A1 Methods of preserving microorganisms
08/12/1998EP0857064A1 Stabilised pharmaceutical preparations containing thyroid hormone
08/12/1998EP0857060A2 Method and preparations for stabilizing biological materials by drying methods without freezing
08/12/1998EP0857020A1 Wet granulation formulation of a growth hormone secretagogue
08/12/1998EP0825848A4 Novel collagen formulations
08/12/1998EP0748215A4 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
08/12/1998EP0741687B1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/12/1998EP0639071B1 Water-in-oil fluid vaccinal emulsions containing a metabolizable oil
08/12/1998EP0613379B1 Therapeutic compounds
08/12/1998CN1190382A Fine particles of petaloid porous hydroxyapatite and process for producing the same
1 ... 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 ... 1712